INBX
NASDAQ · Biotechnology
Inhibrx Biosciences Inc
$84.52
+4.24 (+5.28%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-78.5% upside
Low Target
$12.39
Average Target
$18.13
High Target
$27.56
Current Price
$84.52
Current
$84.52
$84.52
Target
$18.13
$18.13
$12.39
$18.13 avg
$27.56
Scenario Analysis
Bear Case
$12.39
-85.3%
Low target
Base Case
$18.13
-78.5%
Avg target
Bull Case
$27.56
+-67.4%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$155.29
-45.6% from high
52-Week Low
$57.30
+47.5% from low
Target vs 52W High
$18.13
-88.3% vs high
Next Earnings Report
Nov 13, 2026
4d
until earnings
EPS Est: $-2.57
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -41.2% |
| REGN | Buy | 36 | 72% | $76.80 | -91.5% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.7% |